Project description:BackgroundPerinatal mortality is a major global public health concern, especially in sub-Saharan Africa (SSA). Despite perinatal mortality being a major public health concern in SSA, there are very limited studies on the incidence and factors associated with perinatal mortality. Therefore, we aimed to investigate the factors associated with perinatal mortality in SSA.MethodsA secondary data analysis was conducted based on the Demographic and Health Survey (DHS) data of 27 SSA countries. About 314,099 births in the preceding five years of the surveys were considered for the analysis. A multilevel binary logistic regression model was fitted to identify factors associated with perinatal mortality. Deviance (-2Log-Likelihood Ratio (LLR)) was used for model comparison. The Adjusted Odds Ratio (AOR) with the 5% Confidence Interval (CI) of the best-fitted model was used to verify the significant association between factors and perinatal mortality.ResultsThe perinatal mortality rate in sub-Saharan Africa (SSA) was 37.31 per 1,000 births (95% CI: 36.65, 37.98). In the final best-fit model, factors significantly associated with higher perinatal mortality included media exposure (AOR: 1.12, 95% CI: 1.08, 1.17), maternal age ≥ 35 years (AOR: 1.13, 95% CI: 1.06, 1.21), health facility delivery (AOR: 1.10, 95% CI: 1.06, 1.15), having 2-4 births (AOR: 1.35, 95% CI: 1.25, 1.47), five or more births (AOR: 1.69, 95% CI: 1.53, 1.86), residence in West Africa (AOR: 1.30, 95% CI: 1.24, 1.36) or Central Africa (AOR: 1.05, 95% CI: 1.00, 1.11), rural residency (AOR: 1.08, 95% CI: 1.02, 1.13), and difficulty accessing a health facility (AOR: 1.06, 95% CI: 1.02, 1.10). In contrast, factors significantly associated with lower perinatal mortality were a preceding birth interval of 2-4 years (AOR: 0.70, 95% CI: 0.67, 0.74) or five or more years (AOR: 0.91, 95% CI: 0.84, 0.97), Antenatal Care (ANC) visit (AOR: 0.66, 95% CI: 0.63, 0.69), higher education levels (AOR: 0.82, 95% CI: 0.73, 0.93), middle household wealth (AOR: 0.93, 95% CI: 0.88, 0.98), and richer household wealth (AOR: 0.93, 95% CI: 0.87, 0.99).ConclusionPerinatal mortality was a major public health problem in SSA. Maternal socio-demographic, obstetrical, and healthcare-related factors are significantly associated with perinatal mortality. The findings of this study highlighted the need for holistic healthcare interventions targeting enhancing maternal healthcare services to reduce the incidence of perinatal mortality.

Project description:Sub-Saharan Africa represents 69% of the total number of individuals living with HIV infection worldwide and 72% of AIDS deaths globally. Pulmonary infection is a common and frequently fatal complication, though little is known regarding the lower airway microbiome composition of this population. Our objectives were to characterize the lower airway microbiome of Ugandan HIV-infected patients with pneumonia, to determine relationships with demographic, clinical, immunological, and microbiological variables and to compare the composition and predicted metagenome of these communities to a comparable cohort of patients in the US (San Francisco). Bronchoalveolar lavage samples from a cohort of 60 Ugandan HIV-infected patients with acute pneumonia were collected. Amplified 16S ribosomal RNA was profiled and aforementioned relationships examined. Ugandan airway microbiome composition and predicted metagenomic function were compared to US HIV-infected pneumonia patients. Among the most common bacterial pulmonary pathogens, Pseudomonas aeruginosa was most prevalent in the Ugandan cohort. Patients with a richer and more diverse airway microbiome exhibited lower bacterial burden, enrichment of members of the Lachnospiraceae and sulfur-reducing bacteria and reduced expression of TNF-alpha and matrix metalloproteinase-9. Compared to San Franciscan patients, Ugandan airway microbiome were significantly richer, and compositionally distinct with predicted metagenomes that encoded a multitude of distinct pathogenic pathways e.g secretion systems. Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population. Please note that the data from the comparable cohort of patients in the USUS data was published as supplemental material of PMID: 22760045 but not submitted to GEO The 'patient_info.txt' contains 12 clinical, 7 immunological and 3 microbiological variables for each patient.

Project description:Sub-Saharan Africa represents 69% of the total number of individuals living with HIV infection worldwide and 72% of AIDS deaths globally. Pulmonary infection is a common and frequently fatal complication, though little is known regarding the lower airway microbiome composition of this population. Our objectives were to characterize the lower airway microbiome of Ugandan HIV-infected patients with pneumonia, to determine relationships with demographic, clinical, immunological, and microbiological variables and to compare the composition and predicted metagenome of these communities to a comparable cohort of patients in the US (San Francisco). Bronchoalveolar lavage samples from a cohort of 60 Ugandan HIV-infected patients with acute pneumonia were collected. Amplified 16S ribosomal RNA was profiled and aforementioned relationships examined. Ugandan airway microbiome composition and predicted metagenomic function were compared to US HIV-infected pneumonia patients. Among the most common bacterial pulmonary pathogens, Pseudomonas aeruginosa was most prevalent in the Ugandan cohort. Patients with a richer and more diverse airway microbiome exhibited lower bacterial burden, enrichment of members of the Lachnospiraceae and sulfur-reducing bacteria and reduced expression of TNF-alpha and matrix metalloproteinase-9. Compared to San Franciscan patients, Ugandan airway microbiome were significantly richer, and compositionally distinct with predicted metagenomes that encoded a multitude of distinct pathogenic pathways e.g secretion systems. Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population. Please note that the data from the comparable cohort of patients in the USUS data was published as supplemental material of PMID: 22760045 but not submitted to GEO The 'patient_info.txt' contains 12 clinical, 7 immunological and 3 microbiological variables for each patient. The G2 PhyloChip microarray platform (commercially available from Second Genome, Inc.) was used to profile bacteria in lower airway samples from 60 subjects

Project description:BackgroundWe hypothesized that mass distribution of a broad-spectrum antibiotic agent to preschool children would reduce mortality in areas of sub-Saharan Africa that are currently far from meeting the Sustainable Development Goals of the United Nations.MethodsIn this cluster-randomized trial, we assigned communities in Malawi, Niger, and Tanzania to four twice-yearly mass distributions of either oral azithromycin (approximately 20 mg per kilogram of body weight) or placebo. Children 1 to 59 months of age were identified in twice-yearly censuses and were offered participation in the trial. Vital status was determined at subsequent censuses. The primary outcome was aggregate all-cause mortality; country-specific rates were assessed in prespecified subgroup analyses.ResultsA total of 1533 communities underwent randomization, 190,238 children were identified in the census at baseline, and 323,302 person-years were monitored. The mean (±SD) azithromycin and placebo coverage over the four twice-yearly distributions was 90.4±10.4%. The overall annual mortality rate was 14.6 deaths per 1000 person-years in communities that received azithromycin (9.1 in Malawi, 22.5 in Niger, and 5.4 in Tanzania) and 16.5 deaths per 1000 person-years in communities that received placebo (9.6 in Malawi, 27.5 in Niger, and 5.5 in Tanzania). Mortality was 13.5% lower overall (95% confidence interval [CI], 6.7 to 19.8) in communities that received azithromycin than in communities that received placebo (P<0.001); the rate was 5.7% lower in Malawi (95% CI, -9.7 to 18.9), 18.1% lower in Niger (95% CI, 10.0 to 25.5), and 3.4% lower in Tanzania (95% CI, -21.2 to 23.0). Children in the age group of 1 to 5 months had the greatest effect from azithromycin (24.9% lower mortality than that with placebo; 95% CI, 10.6 to 37.0). Serious adverse events occurring within a week after administration of the trial drug or placebo were uncommon, and the rate did not differ significantly between the groups. Evaluation of selection for antibiotic resistance is ongoing.ConclusionsAmong postneonatal, preschool children in sub-Saharan Africa, childhood mortality was lower in communities randomly assigned to mass distribution of azithromycin than in those assigned to placebo, with the largest effect seen in Niger. Any implementation of a policy of mass distribution would need to strongly consider the potential effect of such a strategy on antibiotic resistance. (Funded by the Bill and Melinda Gates Foundation; MORDOR ClinicalTrials.gov number, NCT02047981 .).

Dataset Information

Pattern of disease and determinants of mortality among ICU patients on mechanical ventilator in Sub-Saharan Africa: a multilevel analysis.

Background

Objective

Methods

Results

Conclusion

Trial registration

Publications

Pattern of disease and determinants of mortality among ICU patients on mechanical ventilator in Sub-Saharan Africa: a multilevel analysis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets